SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Despite strong earnings and future AI revenue projections, Broadcom is trending down, sparking community discussion around potential margin compression and customer concentration concerns. The community is debating whether this dip is a buying opportunity or the start of a broader tech sector correction, with some pointing to analyst upgrades as a bullish signal while others express caution about AI valuations.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics is trending due to excitement surrounding potential FDA guidance and a possible buyout, fueled by positive trial data and insider enthusiasm. The community is buzzing about a potential "BABO" (Big-Ass-Buy-Out) and the significance of recent biomarker data, using the term "brownies" as a playful reference. Investors are closely watching for news that could validate the company's prospects in the liver disease treatment space, leading to increased trading volume and speculation.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is trending with significant upward momentum, fueled by community enthusiasm and a narrative linking it to Ethereum's resurgence.  Discussions revolve around a prophecy involving $YEE alongside $DOGE and $PEPE, with many believing it's poised for substantial growth and drawing comparisons to past meme coin successes. The community emphasizes $YEE's potential within the Ethereum ecosystem, with some anticipating exchange listings and broader market recognition.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is gaining attention as investors discuss its potential for a Santa rally and long-term growth, with some community members projecting significant price increases. Discussions also involve comparisons to other cryptocurrencies, particularly Keeta, focusing on transaction speeds and institutional financial applications. Community members are closely monitoring chart patterns and potential breakout points, hoping for a sustained upward trend.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending due to its removal from the Nasdaq 100, triggering fund selling and tax-loss harvesting, though some view this as a buying opportunity amid strong fundamentals. Community discussions revolve around the impact of insider selling and the potential for a turnaround, especially with a recently approved buyback program. Despite the negativity, some traders are optimistic about a potential "January effect" and long-term growth in the connected TV ad space.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to renewed speculation around a past AI server deal and its low float after a reverse split, leading to community discussions about a potential short squeeze. Some traders are comparing it to other low-float runners and anticipating a significant price surge, while noting the stock's recent volatility and potential for both gains and losses. Community members highlight the stock's bullish technical setup and discuss strategies for maximizing potential profits, with many expressing optimism about its prospects.

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

BriaCell Therapeutics Corp - Ordinary Shares - New

BriaCell Therapeutics Corp

BCTX is trending due to recent presentation of Phase 2 survival and Phase 3 clinical data at SABCS, highlighting promising results for its Bria-IMT regimen in metastatic breast cancer, although some investors express concerns about dilution and the company's history of offerings. The community is actively debating the potential for a breakthrough in cancer treatment versus skepticism regarding the company's financials and management. Discussions also include the company's cash runway and potential for a buyout.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is trending downwards as shareholders prepare to vote on a proposed share increase, sparking concerns about dilution; community sentiment is largely bearish, with some pointing to insider selling and lowered price targets as reasons to avoid the stock. Despite the buzz around nuclear energy and SMRs for AI data centers, investors are wary about NuScale's execution and profitability, especially compared to peers like Oklo and Nano Nuclear.

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Exact Sciences Corp.

EXAS is trending as investors discuss its bullish momentum and potential resistance near its 60-day high, with some noting the overbought RSI indicating a possible pullback. Community members are actively evaluating trade plans, take profit targets, and discussing hedging strategies, while some are comparing it to past opportunities and potential buyout scenarios within the broader cancer screening sector.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

SNAP is trending due to discussions around a potential $400 million AI deal with Perplexity, expected to roll out in 2026, which aims to integrate AI search into Snapchat's chat interface. The community is also weighing in on CEO Evan Spiegel's leadership, the company's business model, and the impact of a potential ban on social media for users under 16 in Australia. Sentiment is mixed, with some expressing optimism about SNAP's AI and user growth potential, while others voice concerns about profitability and management.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. It develops a portfolio of clinically validated product candidates for cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications. The company was founded by Konstantin Poukalov on July 17, 2019 and is headquartered in Princeton, NJ.

Current Price	$0.092
Prev Close	$0.0921
Open	$0.107
Dividend Yield	0.00%
50-Day Moving Average	$0.0755
Beta	0.82
Avg. Volume	25,848.58
PE Ratio	N/A

52-Week High	$0.4394
52-Week Low	$0.03
Market Capitalization	$10.04M
EPS (Annual)	$0.0229
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

LIAN
LianBio - ADR

Feed

News

Sentiment

Fundamentals

Info

Latest LIAN News

LIANLianBio - ADR